Will Factor XI Be the Goldilocks Anticoagulant Target?

Sep 22 2023 This Week in CardiologyПодробнее

Factor XI inhibitors: what should clinicians know?Подробнее

Factor XI/XIa Inhibition as a Target for Anticoagulation: The What, Why, and HowПодробнее

Hemophilia C (Factor XI deficiency)Подробнее

FXIa inhibition for secondary stroke prevention: current evidenceПодробнее

Journal Club - Less Bleeding With Factor XI Inhibitor- PACIFIC AF trialПодробнее

Anthos Therapeutics - Anticoagulant in DevelopmentПодробнее

Hematologist's Introduction Factor XI/XIaПодробнее

Emerging Solutions for Safer Anticoagulation: Why Factor XI?Подробнее

ICU 2.0: Revolutionizing Anticoagulation!Подробнее

The importance of thrombosis and hemostasis in hematology & hot topics in hemophilia researchПодробнее

Looking into the future of anticoagulationПодробнее

What are the Blood Clotting Risk Genes?Подробнее

Factor XI Paula Bolton MaggsПодробнее

Novel Therapeutics for Thrombosis and HemostasisПодробнее

PACIFIC-Stroke: the first RCT comparing factor XIa inhibition versus placeboПодробнее

Hemophilia C / Rosenthal syndrome / Factor XI deficiencyПодробнее

Novel oral anticoagulants: Risk score for major bleedingПодробнее

PACIFIC-AMI: Factor XIa inhibitor asundexian on top of DAPT after acute MI - #ESCCongress 2022Подробнее